All In MedTech

FDA Clearance Tracker · P150031-S065

Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 13, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 13, 2024

Approved

Time to decision

411 days

Received Sep 29, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150031-S065
Device name
Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS System
Applicant location
Valencia, CA
Received
Sep 29, 2023
Decided
Nov 13, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150031

Device type

Device class
Class III

Every decision under product code NHL

FDA's approval statement

As written in FDA's record.

which requested approval for the following:• Vercise Cartesia X Directional Lead Kits (Models DB-2203-30B and DB-2203-45B), • Vercise Cartesia HX 16-contact Directional Lead Kits (Models DB-2204-30B and DB-2204-45B), • 16-contact Lead Extension Kits (Models DB-3216-55 and DB-3216-95), • 2x8 Lead Extension Kits (Models DB-3128 and DB-3128-95), and • Vercise Physician’s Spare Kit (Model DB-2501).

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.